LXK INAMI Holding ApS: Financial statements 2019
CVR: 40132635
Source: annual report 2019, Danish Business Authority
02/01/2019 – 31/12/2019
LXK INAMI Holding ApS (CVR 40132635) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 0. Equity in the 2019 report amounted to DKK 1. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 1
- Total Assets
- DKK 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 12, 2019, Michael Dalgaard Zile is registered as director of LXK INAMI Holding ApS.
As of September 12, 2019, Jens Andersen Vexø has stepped down as director of LXK INAMI Holding ApS.
On September 12, 2019, the company changed its name from UK Vexo LXK Medical Group IVS to LXK INAMI Holding IVS.
As of January 2, 2019, Jens Andersen Vexø is registered as director of LXK INAMI Holding ApS.
LXK INAMI Holding ApS was founded on January 2, 2019.
About LXK INAMI Holding ApS
LXK INAMI Holding ApS is a Danish company of the type Anpartsselskab based in Randers C, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named LXK INAMI Holding IVS and UK Vexo LXK Medical Group IVS. The management consists of Michael Dalgaard Zile. The company is owned by Michael Dalgaard Zile and UAB "Medicinos Turizmo Paslaugos". According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,300 and a net result of DKK -20,986 compared with DKK -6,205 the year before. Equity in the 2025 report amounted to DKK -336,107.
